November 23, 2009

Biotech Lobbyists for Higher Drug Costs

Biotech Lobbyists for Higher Drug Costs


This essay describes one example of how health care costs are kept artificially high due to lobbyists controlling the public discourse. The same pattern applies to psychiatric drugs.

http://www.prwatch.org/node/8690

Genentech's Ghostwriting Animates Congressional Speeches on Health Reform
Submitted by Lisa Graves
Center for Media & Democracy
November 15, 2009 - 8:26am.

No comments: